Abstract:Objectives: To investigate the mechanisms of improved myocardial and neurological function and survival following IV administration of cannabinoid receptor agonist, WIN55, 212-2 in a rat model of cardiac arrest.Design: Prospective randomized controlled experimental study.Setting: University-affiliated research institute.Subjects: Thirty male Sprague-Dawley rats.Interventions: Ventricular fibrillation was electrically induced in 30 male Sprague-Dawley rats weighing between 450 and 550g. Cardiopulmonary resuscitation was initiated after 6 minutes of untreated ventricular fibrillation. The precordial compression was performed with a pneumatically driven mechanical chest compressor. No pharmacological agent was used during cardiopulmonary resuscitation. After 8 minutes of cardiopulmonary resuscitation, up to three 2-J defibrillations were attempted. The animals were then randomized into three groups: 1) WIN55, 212-2 hypothermia, 2) WIN55, 212-2 with normal body temperature, and 3) placebo control. Either WIN55, 212-2 (1.0mg/kg/hr) or saline placebo was continuously infused for 2 hours. Except for the WIN55, 212-2 hypothermia group, the body temperature in the other two groups was maintained at 37.00.2 degrees C using an external heating lamp. Postresuscitation myocardial function was measured by echocardiogram. Neurological deficit scores and survival time were observed for up to 72 hours.Measurements and Main Results: Blood temperatures decreased from 37 degrees C to 33 degrees C in 4 hours in animals in WIN55, 212-2 hypothermia group. Myocardial function, as measured by cardiac output, ejection fraction, and myocardial performance index, was significantly impaired in all animals after successful resuscitation when compared with the baseline values. There was a significant improvement in myocardial function in the animals treated with WIN55, 212-2 hypothermia beginning at 1 hour after start of infusion. However, no improvement was observed in the groups of WIN55, 212-2 with normal body temperature and placebo control. WIN55, 212-2 hypothermia group was associated with significantly improved neurologic deficit scores and survival time when compared with placebo control group and WIN55, 212-2 with normal body temperature group.Conclusions: In a rat model of cardiac arrest, better postresuscitation myocardial function, neurological deficit scores, and longer duration of survival were observed by the pharmacologically induced hypothermia with WIN55, 212-2. The improved outcomes of cardiopulmonary resuscitation following administration of WIN55, 212-2 appeared to be the results from its temperature reduction effects.

Abstract 16488: ERK is Invovled in Neuroprotection of Win55,212-2 Pharmacological Hypothermia after CPR in a Rat Cardiac Arrest Model

Abstract 359: the Effect of BDNF on the Neuroprotection of Win55,212-2 Pharmacological Hypothermia after CPR in a Rat Cardiac Arrest Model

Abstract 18789: Pharmacologically Induced Hypothermia with Cannabinoid Receptor Agonist WIN55,212-2 vs Mild Therapeutic Hypothermia in a Rat Model of Cardiac Arrest with Extracorporeal Life Support

Improved Cardiac and Neurologic Outcomes with Postresuscitation Infusion of Cannabinoid Receptor Agonist WIN55, 212-2 Depend on Hypothermia in a Rat Model of Cardiac Arrest.

GW27-e1192 CB1 Receptor Attenuate Neurons Apoptosis to Improve the Outcome of Win55, 212-2 Inducing Hypothermia after Cardiopulmonary Resuscitation in Rats

Cannabinoid 1 (CB1) Receptor Mediates WIN55, 212-2 Induced Hypothermia and Improved Survival in a Rat Post-Cardiac Arrest Model

Abstract 292: Comparison of Pharmacological and Physical Hypothermia in Cerebral and Myocardial Function in a Porcine Model of Cardiac Arrest and Resuscitation

CANNABINOID RECEPTOR AGONIST WIN55: 212-2 ADJUSTS LIPID METABOLISM IN A RAT MODEL OF CARDIAC ARREST

Inhibition of extracellular signal-regulated kinase/calpain-2 pathway reduces neuroinflammation and necroptosis after cerebral ischemia-reperfusion injury in a rat model of cardiac arrest

Spontaneous Hypothermia Ameliorated Inflammation and Neurologic Deficit in Rat Cardiac Arrest Models Following Resuscitation

Pharmacologically Induced Hypothermia with Cannabinoid Receptor Agonist Win55, 212-2 after Cardiopulmonary Resuscitation

Abstract 16870: Pharmacologically Induced Hypothermia with the Cannabinoid Receptor Agonist Win55, 212-2 Improves Microcirculation in a Rat Model of Cardiac Arrest

Abstract 173: the Neuroprotective Effect of JZL184 is Comparable with Therapeutic Hypothermia in a Rat Model of Cardiac Arrest

Pharmacological Inhibition of PERK Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Rats Through the Activation of Akt

Hypothermia Prevents Hippocampal Oxidative Stress and Apoptosis Via the GSK-3β/Nrf2/HO-1 Signaling Pathway in a Rat Model of Cardiac Arrest-Induced Brain Damage

Mild therapeutic hypothermia improves neurological outcomes in a rat model of cardiac arrest

Therapeutic Hypothermia Enhances Cold-Inducible RNA-Binding Protein Expression and Inhibits Mitochondrial Apoptosis in a Rat Model of Cardiac Arrest

Mild Hypothermia Alleviates Cardiomyocyte Necroptosis after Cardiopulmonary Resuscitation by Regulating TRPV1

Abstract 319: Mild Hypothermia Preserves Cerebral Cortex Microcirculation After Resuscitation in a Rat Model of Cardiac Arrest

Abstract 332: Novel Peptide Administered During CPR Improves Long-Term Survival after Prolonged Cardiac Arrest